A Look Ahead: PDS Biotechnology's Earnings Forecast
Benzinga Insights 11 months ago
Earnings
PDS Biotechnology (NASDAQ:PDSB) is preparing to release its quarterly earnings on Thursday, 2025-11-13. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect PDS Biotechnology to report an earnings per share (EPS) of $-0.20.
PDS Biotechnology bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Overview of Past Earnings
The company's EPS beat by $0.03 in the last quarter, leading to a 3.45% increase in the share price on the following day.
Here's a look at PDS Biotechnology's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.24 | -0.25 | -0.28 | -0.28 |
| EPS Actual | -0.21 | -0.21 | -0.21 | -0.29 |
| Price Change % | 3.00 | 3.00 | 1.00 | -11.00 |
Stock Performance
Shares of PDS Biotechnology were trading at $1.06 as of November 11. Over the last 52-week period, shares are down 56.49%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for PDS Biotechnology visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.